{"id":"W2214632401","doi":"10.1200/jco.2006.24.18_suppl.3059","title":"A phase I trial of AEG35156 (XIAP antisense) administered as a continuous intravenous infusion in patients with advanced tumors","year":2006,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Biochemical and Molecular Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":21,"is_retracted":false,"has_abstract":true,"ca_institutions":"Aegera Therapeutics (Canada)","funders":"","keywords":"Medicine; XIAP; Peripheral blood mononuclear cell; Apoptosis; Internal medicine; Gastroenterology; Pharmacology; Programmed cell death; In vitro; Caspase","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001024189,0.0001470372,0.0009234652,0.00009175801,0.0000194995,0.000006824715,0.0002377815,0.0003946702,0.0000164735],"category_scores_gemma":[0.002089867,0.0001061785,0.0002657646,0.0001268338,0.0002718648,0.000006429249,0.00009859858,0.0004662451,0.000002079874],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00002531524,"about_ca_system_score_gemma":0.000840929,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00002952571,"about_ca_topic_score_gemma":0.00003060277,"domain_scores_codex":[0.9969845,0.0003537532,0.00179391,0.0002453603,0.0003520963,0.0002703214],"domain_scores_gemma":[0.9975704,0.0001513335,0.001225447,0.0002079991,0.0006622461,0.0001825655],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.5183439,0.0262475,0.008009145,0.00004189421,0.0001814816,0.0003894857,0.00002232748,0.00001490476,0.2624889,0.00004709193,0.001323644,0.1828898],"study_design_scores_gemma":[0.4289308,0.2889214,0.02332648,0.0001678489,0.00009468285,0.00007794779,0.00004931835,0.000008204876,0.2192571,0.0002658541,0.03856344,0.0003369597],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9980822,0.0001491703,0.00006979812,0.0002370432,0.0002581127,0.0003768155,0.0000084376,0.000001910047,0.0008165262],"genre_scores_gemma":[0.9981748,0.00009013725,0.0009205515,0.0002693133,0.0004039976,0.000004500348,0.00003088937,0.00001662351,0.00008917084],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2626739,"threshold_uncertainty_score":0.4329835,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.0277350046880505,"score_gpt":0.4094865877177187,"score_spread":0.3817515830296682,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}